Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Two Probiotics for Reducing Diarrhea Frequency in Children Aged 6-24 Months
Sponsor: King Edward Medical University
Summary
Clinical Trial Summary The goal of this clinical trial is to compare the effectiveness of Saccharomyces boulardii CNCM I-745 and multi-strain Bacillus clausii in reducing the frequency of acute watery diarrhea in children aged 6 to 24 months. The main question it aims to answer is: \- Which probiotic is more effective in reducing the daily frequency of acute watery diarrhea in children? Researchers will compare Saccharomyces boulardii CNCM I-745 with a four-strain mixture of Bacillus clausii (O/C, SIN, N/R, T) to determine which is more effective in reducing diarrhea frequency. Participants will: * Receive either Saccharomyces boulardii CNCM I-745 at a daily dose of 10 billion CFU or multi-strain Bacillus clausii at a daily dose of 4 billion CFU for 3 days. * Receive standard treatment for diarrhea, including oral rehydration therapy (ORS), zinc supplementation, and dietary advice. * Be followed for 3 days after admission, with daily recording of the frequency of diarrhea episodes.
Official title: Comparison of the Effectiveness of Saccharomyces Boulardii CNCM I-745 and Multi-Strain Bacillus Clausii in Reducing the Frequency of Acute Watery Diarrhea in Children Aged 6 to 24 Months
Key Details
Gender
All
Age Range
6 Months - 24 Months
Study Type
INTERVENTIONAL
Enrollment
88
Start Date
2026-11
Completion Date
2027-02
Last Updated
2026-11-06
Healthy Volunteers
No
Interventions
Saccharomyces boulardii CNCM I-745
Probiotic yeast preparation containing Saccharomyces boulardii CNCM I-745, administered orally at a daily dose of 10 billion colony-forming units (CFU) for 3 days.
Bacillus clausii (O/C, SIN, N/R, T)
Four-strain probiotic preparation containing Bacillus clausii strains O/C, SIN, N/R, and T, administered orally at a daily dose of 4 billion colony-forming units (CFU) for 3 days.